News Headlines Article

America’s $3 billion cancer drug problem
CBS News

American consumers are familiar with the phenomenon of package-shrink, when food manufacturers pack less coffee or sugar into a container but charge the same price. What happens when that strategy is flipped on its head by a life-saving but costly industry?

Look no further than the pharmaceutical sector to find out. Some drugmakers are packaging expensive cancer medicines in doses that are too large for many patients, which leads to $3 billion in wasted cancer medicines annually, according to new research published in the BMJ, which was formerly known as the British Medical Journal.